ES2052173T3 - Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. - Google Patents

Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.

Info

Publication number
ES2052173T3
ES2052173T3 ES90303716T ES90303716T ES2052173T3 ES 2052173 T3 ES2052173 T3 ES 2052173T3 ES 90303716 T ES90303716 T ES 90303716T ES 90303716 T ES90303716 T ES 90303716T ES 2052173 T3 ES2052173 T3 ES 2052173T3
Authority
ES
Spain
Prior art keywords
avermectin
cyclohexil
compositions containing
injectable compositions
parabitants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90303716T
Other languages
English (en)
Spanish (es)
Inventor
Stephen Richard Wicks
Edward Davison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908071A external-priority patent/GB8908071D0/en
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2052173T3 publication Critical patent/ES2052173T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
ES90303716T 1989-04-11 1990-04-06 Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. Expired - Lifetime ES2052173T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908071A GB8908071D0 (en) 1989-04-11 1989-04-11 Antiparasitic formulations
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1

Publications (1)

Publication Number Publication Date
ES2052173T3 true ES2052173T3 (es) 1994-07-01

Family

ID=26295191

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90303716T Expired - Lifetime ES2052173T3 (es) 1989-04-11 1990-04-06 Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.

Country Status (16)

Country Link
EP (1) EP0393890B1 (OSRAM)
JP (1) JPH0647548B2 (OSRAM)
CN (1) CN1035356C (OSRAM)
AP (1) AP133A (OSRAM)
AU (1) AU609660B2 (OSRAM)
CY (1) CY1777A (OSRAM)
DK (1) DK0393890T3 (OSRAM)
EG (1) EG18956A (OSRAM)
ES (1) ES2052173T3 (OSRAM)
FI (1) FI92015C (OSRAM)
GR (1) GR3005794T3 (OSRAM)
HK (1) HK39294A (OSRAM)
NO (1) NO175882C (OSRAM)
OA (1) OA09203A (OSRAM)
RU (1) RU1836084C (OSRAM)
SG (1) SG27894G (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
EP0928136B1 (en) * 1996-06-05 2003-10-22 Ashmont Holdings Limited Injectable compositions
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
WO2010008891A2 (en) * 2008-06-24 2010-01-21 Merial Limited Anthelminthic formulations
DK2396006T3 (da) * 2009-02-16 2013-02-11 Ah Usa 42 Llc Doramectinformulering med høj dosis
BR112012008185A2 (pt) * 2009-10-07 2016-08-16 Wyeth Llc composições que compreendem adjuvante, macrolídeo e antígeno proteináceo, e métodos para uso dessas composições

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2166436B (en) * 1984-09-14 1989-05-24 Glaxo Group Ltd Antibiotic compounds and their preparation
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
ES2045146T3 (es) * 1987-11-09 1994-01-16 Pfizer Avermectinas etiladas.

Also Published As

Publication number Publication date
OA09203A (fr) 1992-06-30
AP133A (en) 1991-06-05
GR3005794T3 (OSRAM) 1993-06-07
EP0393890A1 (en) 1990-10-24
HK39294A (en) 1994-05-06
RU1836084C (ru) 1993-08-23
EP0393890B1 (en) 1992-08-12
AP9000174A0 (en) 1990-04-30
NO901637L (no) 1990-10-12
EG18956A (en) 1994-04-30
CN1046282A (zh) 1990-10-24
NO175882C (no) 1994-12-28
NO175882B (no) 1994-09-19
NO901637D0 (no) 1990-04-10
FI92015B (fi) 1994-06-15
AU5311990A (en) 1990-11-08
JPH0647548B2 (ja) 1994-06-22
DK0393890T3 (da) 1992-09-28
AU609660B2 (en) 1991-05-02
SG27894G (en) 1995-03-17
CY1777A (en) 1995-10-20
CN1035356C (zh) 1997-07-09
FI901816A0 (fi) 1990-04-10
FI92015C (fi) 1994-09-26
JPH02290820A (ja) 1990-11-30

Similar Documents

Publication Publication Date Title
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
ES2175125T3 (es) Emulsionantes aceite/agua.
AR002932A1 (es) Solucion acuosa de interferon
AR240958A1 (es) Una composicion detergente acuosa que comrende un gel".
ES2124479T3 (es) Composiciones biocidas.
ES2060647T3 (es) Composicion blanqueante.
DE69529998D1 (de) Glp-1 zusammensetzungen mit verlängerter wirkdauer
ES2114487B1 (es) Mezcla estabilizante sinergistica.
ES2140473T3 (es) Derivado fosfolipido y liposoma que lo contiene.
MX9102016A (es) Composicion detergente
ES2072452T3 (es) Medios cosmeticos desodorizantes.
TR25422A (tr) Poliol poliesterler ve azalmtilmis kalorili trigliseritler iceren azaltilmis kalorili yag bilesimleri.
DE3872398D1 (de) Enzymatische waschmittelzusammensetzung.
ES2116279T3 (es) Composicion de caucho.
DE69815549D1 (de) Pestizide zusammensetzung
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
DE68918561D1 (de) Bleichzusammensetzung.
ES2052173T3 (es) Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
DE68917777D1 (de) Enzymatische Waschmittelzusammensetzung.
ES2022324B3 (es) Lubricantes que contienen agentes tensioactivos carboxilados, produccion y uso.
BR9504771A (pt) Composição anidra de uso tópico e processo de preparação de uma composição
ES2054106T3 (es) Acetales de oxotetralinas y de oxoindanos.
CO4600725A1 (es) Composiciones insecticidas sinergisticas
ES2045768T3 (es) Composiciones topicas que contienen defibrotida.
MX170928B (es) Composicion limpiadora para superficies duras

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 393890

Country of ref document: ES